Загрузка...
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology. Patients present loss of lung function, dyspnea and dry cough. Diagnosis requires compatible radiologic imaging and, in undetermined cases, invasive procedures such as bronchoscopy and surgical lung biopsy....
Сохранить в:
| Опубликовано в: : | Respir Res |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5764001/ https://ncbi.nlm.nih.gov/pubmed/29321022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-018-0714-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|